Now we'll see if this news has any meaning at all. I don't anticipate that litho approval will generate a lot of revenue this year or next but I'm curious how the market will react to this news. Maybe up $.50-$.75 a share to $4 as the new support level? I just don't know.
A lot of shares bought in the $3.35 range... so folks are selling the news with a 10% gain and moving on... such a low float stock, most anything can happen... but no real move to the upside even w-FDA approval until there is verified revenue... IMO will base at $4 until revenue is visible..